The company has repeatedly denied accusations lobbed against its business model.

The last time the nutritional-supplement maker fell short of Wall Street’s targets was in the fourth-quarter of 2008, when its quarterly earnings-per-share missed estimates by a penny. Excluding today’s figures, the stock has risen the next day following 14 of those 18 quarterly beats.